Tumores sellares y suprasellares que afectan al quiasma y nervios ópticos. I. Consideraciones generales

González Almaraz, Gabriel; Pineda Cárdenas, María A. Araceli.
Rev. mex. oftalmol ; 71(6): 216-25, nov.-dic. 1997. tab, ilus
Artículo en Español | LILACS | ID: lil-227487

Documentos relacionados

  1. [Aggressive pituitary tumors and carcinomas: modern classification, advances and prospects in treatment].
  2. Metastatic Spread to the Pituitary.
  3. The hallmarks of cancer… in pituitary tumors?
  4. Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study.
  5. [Molecular Mechanisms of Pituitary Tumorigenesis].
  6. Evidence for Dual Activation of <i>I</i><sub>K(M)</sub> and <i>I</i><sub>K(Ca)</sub> Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one).
  7. The Evidence for Effective Inhibition of <i>I</i><sub>Na</sub> Produced by Mirogabalin ((1R,5S,6S)-6-(aminomethyl)-3-ethyl-bicyclo [3.2.0] hept-3-ene-6-acetic acid), a Known Blocker of Ca<sub>V</sub> Channels.
  8. [Plurihormonal PIT1-lineage pituitary neuroendocrine tumors: a clinicopathological study].
  9. [Epidemiology, Genetics and Pathogenesis of Pituitary Neuroendocrine Tumors].
  10. Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.